CFTR and cystic fibrosis: CFTR modulator therapies currently administered to F508del homozygotes CF patients include Orkambi® (composed of lumacaftor, a CFTR trafficking corrector, and ivacaftor, an activity potentiator) and Symdeko® (which includes ivacaftor and tezacaftor, a closely related derivative of lumacaftor) [9].